Veterinary Medicines

LAOCAINE

Authorised
  • Lidocaine hydrochloride monohydrate
Download as PDF

Product identification

Medicine name:
LAOCAINE
Active substance:
  • Lidocaine hydrochloride monohydrate
Target species:
  • Dog
  • Cat
  • Equid
Route of administration:
  • Epidural use
  • Subcutaneous use

Product details

Active substance and strength:
  • Lidocaine hydrochloride monohydrate
    20.00
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for injection
Withdrawal period by route of administration:
  • Epidural use
    • Equid
      • Meat and offal
        3
        day
      • Milk
        3
        day
  • Subcutaneous use
    • Equid
      • Meat and offal
        3
        day
      • Milk
        3
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QN01BB02
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • France
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Legal basis not covered by Directive 2001/82/EC
Marketing authorisation holder:
  • Intervet
Marketing authorisation date:
Manufacturing sites for batch release:
  • Trirx Segre
Responsible authority:
  • French Agency For Food, Environmental And Occupational Health & Safety
Authorisation number:
  • FR/V/1327125 5/1980
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
French (PDF)
Published on: 4/04/2022
Download